section name header

Pronunciation

dex-ra-ZOX-ane

Classifications

Therapeutic Classification: cardioprotective agents

Indications

REMS


Action

  • Acts as an intracellular chelating agent.
Therapeutic effects:
  • Diminishes the cardiotoxic effects of doxorubicin.
  • Decreased damage from extravasation of anthracyclines.

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Well distributed to tissues.

Metabolism/Excretion: Some metabolism occurs; 42% eliminated in urine.

Half-Life: 2.1–2.5 hr.

Time/Action Profile

(cardioprotective effect)

ROUTEONSETPEAKDURATION
IVrapidunknownunknown





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Cardioprotective

Renal Impairment

Extravasation Treatment

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Totect

Canadian Brand Names

Zinecard